Literature DB >> 7655832

Cognitive deficits in patients with small cell lung cancer before and after chemotherapy.

C A Meyers1, K S Byrne, R Komaki.   

Abstract

We conducted a prospective study of cognitive function in patients with small cell lung cancer (SCLC). A previous study had shown SCLC patients to have deficits in memory, frontal lobe executive functioning, and motor skills before they received prophylactic cranial irradiation (PCI). This study was performed to determine whether these deficits were related to chemoradiation treatment. We evaluated two groups of patients: one newly diagnosed and untreated, the other post-chemoradiation and before PCI. Strict eligibility criteria were used to minimize any preexisting factors that might influence cognitive functioning. Results showed that patients with SCLC have cognitive deficits before receiving chemoradiation, specifically on tests of verbal memory, frontal lobe executive functions, and motor coordination. There was no difference between the treated and untreated patients on any test. Etiologic considerations currently under study include paraneoplastic phenomena.

Entities:  

Mesh:

Year:  1995        PMID: 7655832     DOI: 10.1016/0169-5002(95)00446-8

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  21 in total

Review 1.  Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.

Authors:  Heather L McGinty; Kristin M Phillips; Heather S L Jim; Julie M Cessna; Yasmin Asvat; Mallory G Cases; Brent J Small; Paul B Jacobsen
Journal:  Support Care Cancer       Date:  2014-05-25       Impact factor: 3.603

Review 2.  Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction.

Authors:  Christopher Loiselle; Jason Rockhill
Journal:  Curr Pain Headache Rep       Date:  2009-08

3.  Neurocognitive function in head and neck cancer patients prior to treatment.

Authors:  Stewart M Bond; Mary S Dietrich; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-01-13       Impact factor: 3.603

4.  A prospective study of cognitive function in men with non-seminomatous germ cell tumors.

Authors:  Jeffrey S Wefel; Damon J Vidrine; Salma K Marani; Richard J Swartz; Tracy L Veramonti; Christina A Meyers; Harald J Hoekstra; Josette E H M Hoekstra-Weebers; Ellen R Gritz
Journal:  Psychooncology       Date:  2013-12-16       Impact factor: 3.894

5.  Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options.

Authors:  Fulvia Di Iulio; Luca Cravello; Jacob Shofany; Stefano Paolucci; Carlo Caltagirone; Giovanni Morone
Journal:  Neurol Sci       Date:  2019-05-02       Impact factor: 3.307

6.  Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

Authors:  Lisa A Hammond-Thelin; Melanie B Thomas; Michiko Iwasaki; James L Abbruzzese; Yvonne Lassere; Christina A Meyers; Paulo Hoff; Johann de Bono; Jody Norris; Hitoshi Matsushita; Akira Mita; Eric K Rowinsky
Journal:  Invest New Drugs       Date:  2010-09-14       Impact factor: 3.850

Review 7.  Neuropsychological sequelae of non-central nervous system cancer and cancer therapy.

Authors:  Jeffrey S Wefel; Mariana E Witgert; Christina A Meyers
Journal:  Neuropsychol Rev       Date:  2008-04-16       Impact factor: 7.444

8.  Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.

Authors:  Desiree Jones; Elisabeth G Vichaya; Xin Shelley Wang; Mary H Sailors; Charles S Cleeland; Jeffrey S Wefel
Journal:  Cancer       Date:  2013-09-16       Impact factor: 6.860

9.  Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors.

Authors:  Stephanie A Reid-Arndt; Albert Yee; Michael C Perry; Catherine Hsieh
Journal:  J Psychosoc Oncol       Date:  2009

10.  Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.

Authors:  Stephanie A Reid-Arndt; Catherine Hsieh; Michael C Perry
Journal:  Psychooncology       Date:  2010-05       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.